Abstract:The gut microbiome is implicated in the pathology of colorectal cancer (CRC). However, the mechanisms by which the microbiota actively contribute to disease onset and progression remain elusive. In this pilot study, we sequenced fecal metatranscriptomes of 10 non-CRC and 10 CRC patient gut microbiomes and conducted differential gene expression analyses to assess any changed functionality in disease. We report that oxidative stress responses were the dominant activity across cohorts, an overlooked protective housekeeping role of the human gut microbiome. However, expression of hydrogen peroxide and nitric oxide-scavenging genes was diminished and augmented, respectively, positing that these regulated microbial responses have implications for CRC pathology. CRC microbes enhanced expression of genes for host colonization, biofilm formation, genetic exchange, virulence determinants, antibiotic, and acid resistances. Moreover, microbes promoted transcription of genes involved in metabolism of several beneficial metabolites, suggesting their contribution to patient metabolite deficiencies previously solely attributed to tumor cells. We showed in vitro that expression of genes involved in amino acid-dependent acid resistance mechanisms of meta-gut Escherichia coli responded differently to acid, salt, and oxidative pressures under aerobic conditions. These responses were mostly dictated by the host health status of origin of the microbiota, suggesting their exposure to fundamentally different gut conditions. These findings for the first time highlight mechanisms by which the gut microbiota can either protect against or drive colorectal cancer and provide insights into the cancerous gut environment that drives functional characteristics of the microbiome. IMPORTANCE The human gut microbiota has the genetic potential to drive colorectal cancer onset and progression; however, the expression of this genetic potential during the disease has not been investigated. We found that microbial expression of genes that detoxify DNA-damaging reactive oxygen species, which drive colorectal cancer, is compromised in cancer. We observed a greater activation of expression of genes involved in virulence, host colonization, exchange of genetic material, metabolite utilization, defense against antibiotics, and environmental pressures. Culturing gut Escherichia coli of cancerous and noncancerous metamicrobiota revealed different regulatory responses of amino acid-dependent acid resistance mechanisms in a health-dependent manner under environmental acid, oxidative, and osmotic pressures. Here, for the first time, we demonstrate that the activity of microbial genomes is regulated by the health status of the gut in vivo and in vitro and provides new insights for shifts in microbial gene expression in colorectal cancer.

Commensal microbiota from patients with inflammatory bowel disease produce genotoxic metabolites

Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer

Human Intestinal Lumen and Mucosa-Associated Microbiota in Patients with Colorectal Cancer

The Colorectal Cancer Microbiota Alter Their Transcriptome To Adapt to the Acidity, Reactive Oxygen Species, and Metabolite Availability of Gut Microenvironments

Colorectal cancer-associated bacteria are broadly distributed in global microbiomes and drivers of precancerous change

Gut microbiome: decision-makers in the microenvironment of colorectal cancer

Integrated analysis of the gut microbiome and metabolome in a mouse model of inflammation-induced colorectal tumors

Commensal microbiota-derived metabolite agmatine triggers inflammation to promote colorectal tumorigenesis

Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota

Colorectal cancer: role of commensal bacteria and bystander effects

Gut Microbiota-Derived Metabolites in Colorectal Cancer: The Bad and the Challenges

Insights from Human and Mouse Models

Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease

Gut microbiota-derived metabolites in CRC progression and causation

Microbiota-derived small molecule genotoxins: host interactions and ecological impact in the gut ecosystem

Microbiota regulation of intestinal inflammation influences colorectal cancer

Microbial genotoxin-elicited host DNA mutations related to mitochondrial dysfunction, a momentous contributor for colorectal carcinogenesis

Colorectal cancer-associated microbiota contributes to oncogenic epigenetic signatures

Metagenome Analysis of Intestinal Bacteria in Healthy People, Patients With Inflammatory Bowel Disease and Colorectal Cancer

Interaction between microbiota and immunity and its implication in colorectal cancer

Limiting oxidative DNA damage reduces microbe-induced colitis-associated colorectal cancer